SCHEMBL22964202

SCHEMBL22964202

CC(C)(O)CCNC(=O)c1cnc2ccc(-c3cncs3)cc2c1NC1COC1

nearest known ligand 0.46

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ CD38 P28907 12/20 0.46
▸ IRAK4 Q9NWZ3 5/20 0.45
▸ KCNH2 Q12809 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ ATR Q13535 1/20 0.40
▸ MELK Q14680 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29725384 1.00 CD38 (0.46) CD38IRAK4KCNH2ATMATR
SCHEMBL22963961 0.86 IRAK4 (0.48) IRAK4
SCHEMBL29725441 0.86 IRAK4 (0.48) IRAK4
SCHEMBL22964204 0.84 CD38 (0.50) CD38IRAK4KCNH2ATMATR
SCHEMBL29725408 0.84 CD38 (0.50) CD38IRAK4KCNH2ATMATR
SCHEMBL22964207 0.84 MELK (0.55) IRAK4KCNH2ATMATRMELK
SCHEMBL29725386 0.84 MELK (0.55) IRAK4KCNH2ATMATRMELK
SCHEMBL22964171 0.73 MELK (0.53) IRAK4MELK
SCHEMBL29725490 0.73 MELK (0.53) IRAK4MELK
SCHEMBL22964257 0.72 IRAK4 (0.46) CD38IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114174279-B Bicyclic heterocyclic compounds useful as IRAK4 inhibitors 百时美施贵宝公司 2024-07-02 — — CN claimed
CN-114174279-A Bicyclic heterocyclic compounds useful as IRAK4 inhibitors 百时美施贵宝公司 2022-03-11 — — CN claimed
CN-114174279-B Bicyclic heterocyclic compounds useful as IRAK4 inhibitors 百时美施贵宝公司 2024-07-02 — — CN disclosed
CN-114174279-A Bicyclic heterocyclic compounds useful as IRAK4 inhibitors 百时美施贵宝公司 2022-03-11 — — CN disclosed
WO-2021026181-A1 BICYCLIC HETEROCYCLIC COMPOUNDS USEFUL AS IRAK4 INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2021-02-11 — — WO disclosed
Send feedback